Seagen (United States)
In research, Seagen (United States) stands highest in Health Sciences (#1,849 of 16,688 worldwide), Medicine (#2,193 of 14,558 worldwide) and Life Sciences (#2,838 of 11,023 worldwide), over all time. Relative to its size it is most specialised in Oncology (Oncology is 21.0× its share of world research).
- World rank, 2022-now
- #21,633 of 22,385 · #6,463 all time
- Rank in United States
- #3,205 of 3,332
- Research works
- 613 ▼ 34% vs 2018-21
- Citations
- 56k 90.7 per fractional work
- Top-10% rate
- 14.0% all institutions 10.0%
- vs its own fields
- 1.00× 1.00× is exactly expected
- Open access
- 30% world 40%
- International
- 14% world 18%
What is Seagen (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #1,849 of 16,688 | 24.3% | 380 | |
| MedicineField | #2,193 of 14,558 | 24.0% | 371 | |
| Life SciencesDomain | #2,838 of 11,023 | 17.3% | 181 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,772 of 5,801 | 18.1% | 130 | |
| OncologySubfield | #499 of 1,474 | 24.7% | 129 |
Each strip is that field's whole ranked pool, with the notch where Seagen (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Seagen (United States) work in?
In 2022-now, 69% of research at Seagen (United States) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (6%). It does 2.7× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 20 fields, with their numbers
- Health Sciences5968.6%
- Medicine5867.3%
- Health Professions00.5%
- Veterinary00.4%
- Nursing00.3%
- Dentistry00.1%
- Life Sciences1619.0%
- Physical Sciences78.5%
- Engineering33.0%
- Computer Science11.7%
- Chemistry11.6%
- Mathematics11.1%
- Materials Science10.8%
- Environmental Science00.4%
- Social Sciences33.9%
- Economics, Econometrics and Finance33.1%
- Social Sciences00.4%
- Decision Sciences00.2%
- Psychology00.2%
What does Seagen (United States) specialise in?
Where its research is concentrated relative to its size: Oncology takes 21.0× the share of its output that it takes of world research.
- OncologySubfield · 20.4 works21×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.
All 20 fields, with their numbers
- Immunology and Microbiology6.02×5 works
- Medicine3.50×58 works
- Veterinary2.99×0 works
- Biochemistry, Genetics and Molecular Biology2.16×10 works
- Pharmacology, Toxicology and Pharmaceutics1.93×1 works
- Economics, Econometrics and Finance1.43×3 works
- Chemistry1.04×1 works
- Mathematics0.91×1 works
- Nursing0.66×0 works
- Neuroscience0.29×0 works
- Decision Sciences0.25×0 works
- Computer Science0.22×2 works
- Materials Science0.22×1 works
- Engineering0.20×3 works
- Health Professions0.19×0 works
- Dentistry0.11×0 works
- Environmental Science0.07×0 works
- Psychology0.07×0 works
- Agricultural and Biological Sciences0.05×0 works
- Social Sciences0.04×0 works
- Immunology and Microbiology 6.0×
- Medicine 3.5×
- Veterinary 3.0×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Economics, Econometrics and Finance 1.4×
- Chemistry 1.0×
- Mathematics 0.9×
- Nursing 0.7×
- Neuroscience 0.3×
- Decision Sciences 0.2×
- Computer Science 0.2×
- Materials Science 0.2×
- Engineering 0.2×
- Health Professions 0.2×
- Dentistry 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.0×
Who are the top researchers at Seagen (United States)?
Ranked on the quality score, Peter D. Senter, Shyra J. Gardai and Che‐Leung Law lead among researchers whose main affiliation is Seagen (United States).
- 1
Peter D. Senter
United States · #71,519 worldwide 18k citations · 236 works
- 2
Shyra J. Gardai
United States · #102,981 worldwide 5.7k citations · 199 works
- 3
Che‐Leung Law
United States · #114,295 worldwide 7.1k citations · 274 works
- 4
Paul J. Carter
United States · #118,206 worldwide 6.8k citations · 99 works
- 5
Iqbal S. Grewal
United States · #125,534 worldwide 13k citations · 191 works
- 6
Martha E. Anderson
United States · #150,143 worldwide 3.2k citations · 97 works
- 7
Alan F. Wahl
United States · #152,493 worldwide 8.6k citations · 85 works
- 8
Mechthild Jonas
United States · #157,416 worldwide 5k citations · 109 works
- 9
Nicole M. Okeley
United States · #222,906 worldwide 4k citations · 128 works
- 10
Ivan J. Stone
United States · #239,952 worldwide 2.5k citations · 121 works
Which keywords describe research at Seagen (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Immunotherapy, Trastuzumab, Monoclonal Antibody, Metastatic, Lymphoma and EGFR.
- PD-1 and PD-L1
- Metastatic Breast Cancer
- Bladder Cancer
- Chimeric Antigen Receptor
- Leukemia
- ALK Inhibitors
- Treatment Guidelines
- Tumor Regression
- Classification
- Cancer Immunotherapy
- Gene Expression Profiling
- Molecular Characterization
- Antibody Engineering
- Rituximab
- Targeted Therapy
- Monoclonal Antibodies
- EGFR
- Lymphoma
- Monoclonal Antibody
- Breast Cancer
- Chemotherapy
- Immunotherapy
- Trastuzumab
- Metastatic
- HER2
- Glycosylation
- PET Imaging
- Therapeutic Antibodies
- Fc Receptors
- Clinical Trials
- Molecular Profiling
- Neoadjuvant Therapy
- Genetic Pathogenesis
- Genomic Profiling
- Tumor Microenvironment
- EGFR Mutations
- CAR T Cells
- Prognostic Factors
- Urothelial Carcinoma
- Immune Checkpoint Blockade
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy17▲ 28×15 topics
- Breast Cancer10▲ 47×3 topics
- Immunotherapy10▲ 16×13 topics
- Monoclonal Antibody8▲ 173×2 topics
- Trastuzumab8▲ 191×2 topics
- Lymphoma8▲ 58×3 topics
- Metastatic8▲ 143×2 topics
- EGFR8▲ 287×1 topic
- HER28▲ 287×1 topic
- Monoclonal Antibodies6▲ 83×3 topics
- Glycosylation6▲ 61×3 topics
- Targeted Therapy6▲ 30×5 topics
- PET Imaging6▲ 38×5 topics
- Rituximab5▲ 43×2 topics
- Therapeutic Antibodies5▲ 90×2 topics
- Antibody Engineering5▲ 107×1 topic
- Fc Receptors5▲ 107×1 topic
- Molecular Characterization5▲ 32×4 topics
- Clinical Trials5▲ 8.2×7 topics
- Gene Expression Profiling5▲ 70×2 topics
- Molecular Profiling5▲ 58×2 topics
- Cancer Immunotherapy5▲ 35×3 topics
- Neoadjuvant Therapy4▲ 22×4 topics
- Classification4▲ 11×1 topic
- Genetic Pathogenesis4▲ 97×1 topic
- Tumor Regression4▲ 43×2 topics
- Genomic Profiling4▲ 45×2 topics
- Treatment Guidelines4▲ 21×2 topics
- Tumor Microenvironment4▲ 10×4 topics
- ALK Inhibitors4▲ 74×1 topic
- EGFR Mutations4▲ 74×1 topic
- Leukemia4▲ 51×2 topics
- CAR T Cells4▲ 55×1 topic
- Chimeric Antigen Receptor4▲ 55×1 topic
- Prognostic Factors4▲ 9.2×10 topics
- Bladder Cancer3▲ 101×1 topic
- Urothelial Carcinoma3▲ 88×1 topic
- Metastatic Breast Cancer3▲ 65×2 topics
- Immune Checkpoint Blockade3▲ 33×1 topic
- PD-1 and PD-L13▲ 33×1 topic
Which research topics does Seagen (United States) publish most on?
By volume in 2022-now: HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HER2/EGFR in Cancer Research Oncology 8 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 5 CAR-T cell therapy research Oncology 4 works
- 6 Bladder and Urothelial Cancer Treatments Surgery 3 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 9 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 10 Colorectal Cancer Treatments and Studies Oncology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Seagen (United States)'s research output changed?
Output in 2022-2025 was 34% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Seagen (United States) as a percentage of every work published that year, 0.00027% in 2024.
Fractional works of Seagen (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 39.4% in 2014.
Other research institutions in Bothell
- Modern Electron (United States)
- Radar (United States)
- EKOS Corporation
- Epoch Biosciences (United States)
- OncoGenex Pharmaceuticals (United States)
- Sonic Concepts (United States)
- Ondine Biopharma (United States)
- Helix Biomedix (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Seagen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
